Table 1. Standard pharmacological treatment for Alzheimer disease.
Drug | Company of origen | Action | AD Patient status | Efficacy |
---|---|---|---|---|
Donezepil | Eisai | AChI | Mild to moderate | Improve cog., beh., DL |
Rivastigmine | Novartis | AChI | Mild to moderate | Improve cog., beh., DL |
Galantamine | Janssen | AChI | Mild to moderate | Improve cog., beh., DL |
Memantine | Allergan | NMDAR antagonist | Moderate to severe | Improve cog. |
AChI: Acetylcholinestarase inhibitor; NMDAR: N-Methyl-D-aspartate receptor;
Cog: Cognition; Beh: Behaviour: DL: Daily life activities
Source: http://www.clinicaltrials.gov